Skip to main content
. 2021 Apr 12;12:649414. doi: 10.3389/fphar.2021.649414

TABLE 1.

Patient characteristics.

Number of patients, n 8
Gender, M/F 6/2
Age (years) 53.3 ± 3.4
Heart rate (beats min−1) a 58.4 ± 4.0
PR interval (ms) a 179.5 ± 10.2
QRS interval (ms) a 102.0 ± 9.4
QTc interval (ms) a 431.0 ± 9.2
Hypertension, n 5
Pulmonary hypertension, n 1
Diabetes, n N/A
ACE inhibitors, n 6
Ca2+ antagonists, n 1
Class IC blockers, n 4
Class II blockers, n 2
Class III blockers, n 5
Lipid-lowering drugs, n 4
a

In sinus rhythm. ACE, angiotensin-converting enzyme.